baber/WOPTO huggingface dataset:
Patent NZ-324673-A (NZ)
Title: A fluid bed apparatus, a bed plate, and a method of making a bed plate
Inventor: CHRISTENSEN MOGENS AXEL
IPC: B01J8/44
Filed: 1996-12-18
Abstract: A bed plate (13) for a fluid bed apparatus comprises a great plurality of bulges or dents (27) each having at least one through-going gas flow opening (29, 31) defined therein. Conventional bed plates having openings of the gill type inevitably comprise small cracks or notches formed in the edge portion defining each of the gas flow openings. According to the invention the gas flow openings (29, 31) are formed in the bulges or dents (27) in a manner so as to exclude the formation of such notches in the edge portion. This may, for example, be done by forming such openings with crack free edges prior to or after the formation of the bulges or dents (29, 31). Thus, the openings may be formed by punching, drilling, laser cutting or the like. Each of the gas flow openings is directed in relation to the plane of the bed plate so as to cause a flow of gas, which is passed through the opening, to contact an adjacent part of the bed plate, which interconnects the bulges or dents (29, 31).
Patent NZ-329188-A (NZ)
Title: Use of an estrogen agonist/antagonist such as tamoxifen or raloxifene for treating atherosclerosis
Inventor: AIELLO ROBERT JOSEPH
IPC: A61K31/4535
Filed: 1997-11-14
Abstract: The specification describes the use of 4-hydroxy tamoxifene, raloxifene, toremifene, centchroman, idoxifene, 6,(4-hydroxy-phenyl)-5-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-naphthalen-2-ol or {4-[2-aza-bicyclo[2.2.1]hept-2-yl)-ethoxy]-phenyl}-[6-hydroxy-2-(4-hydroxy-phenyl)-benzo[b]thiophen-3-yl]-methanone to treat atherosclerosis, independent of lipid lowering.  The mechanism by which these drugs acts is by inhibiting progression of an atherogenic lesion or by stabilising plaque buildup.
Patent NZ-330471-A (NZ)
Title: Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors
Inventor: GARFIELD ROBERT E
IPC: A61K31/00
Filed: 1997-01-21
Abstract: The specification describes the use of: (i)	an effective amount of a nitric oxide synthase substrate, such as L-arginine, and a nitric oxide donor such as, sodium nitroprusside, nitroglycerin, glyceryl trinitrate, SIN-1, isosorbid mononitrate or isosorbid dinitrate, or both and optionally (ii)	one or more progestin, an estrogen and a partial agonist' for treating urinary incontinence symptoms in a female mammal.
Patent NZ-331194-A (NZ)
Title: Stress plate with depending sleeve for use with threaded fastener for securing soft insulation
Inventor: HASAN S RIAZ
IPC: E04D5/14
Filed: 1998-07-31
Abstract: stress plate 10 for use with a threaded fastener for securing a member to a base structure, comprises a planar main body 12 disposed within a first plane and having an outer peripheral edge 14 vertically spaced from the first plane so as to be disposed within a second plane.  Stress plate 10 has a predetermined thickness dimension, and a recessed portion 20, having an upper portion commencing within the first plane of the planar main body and a lower portion terminating within the second plane of the outer peripheral edge of the planar main body such that the recessed portion has a depth substantially equal to the predetermined thickness dimension of stress plate 10, defined within a central portion of stress plate 10 for accommodating a head portion of a threaded fastener to be inserted through stress plate 10 in order to secure a member to a base structure.  An aperture 22 is defined within a central portion of stress plate 10 and is coaxial with recessed portion 20 of planar main body 12 for receiving a threaded shank portion of a threaded fastener.  A non-threaded, cylindrical, tubular sleeve means 38, having opposite upper and lower ends, circumscribes aperture 22, and has a predetermined axial length such that the upper end of tubular sleeve means 38 is integral with the lower portion of recessed portion 20 of planar main body 12 such that tubular sleeve means 38 and recessed portion 20 of planar main body 12 comprise a one-piece structure.  The upper end of tubular sleeve means 38 is disposed within the second plane of outer peripheral edge 14 of planar main body while the lower end of tubular sleeve means 38 depends axially downwardly from recessed portion 20 of planar main body 12 a predetermined distance below the second plane defined by outer peripheral edge 14 of planar main body 12.  The upper end of tubular sleeve 38 is for receiving a threaded shank portion of a threaded fastener when a threaded fastener is inserted through aperture 22 and is for engaging only the crest portions of a threaded portion of a threaded fastener when a threaded fastener is inserted through aperture 22 defined within planar main body 12 so as to maintain a threaded fastener perpendicular to stress plate 10.
Patent NZ-331969-A (NZ)
Title: lot machine game with dynamic special symbols on a secondary display
Inventor: BENNETT NICHOLAS LUKE
IPC: G07F17/34
Filed: 1997-02-21
Abstract: A slot machine (20) which provides a plurality of rotatable reels (30) carrying symbols (31) is arranged to pay a prize on the occurrence of a predetermined symbol or combination of symbols. As well as the predetermined prize winning combinations listed on the artwork (35) of top box (32), a special symbol display (33) is provided within the artwork panel to display a special symbol for use in determining additional winning combinations. Typically, the special symbol will be used as a wildcard symbol such that when a game is played any occurrence of the currently displayed wildcard symbol in the game display will count as any other symbol when determining if any winning combinations have occurred.
Patent NZ-332894-A (NZ)
Title: A regimen containing progestogen and/or estrogen with two or more anti-progestogen dosage units
Inventor: COELINGH BENNINK HERMAN JAN TI
IPC: A61K31/56
Filed: 1997-06-23
Abstract: Disclosed is a contraceptive and/or HRT (hormone replacement therapy) kit comprising sequential daily dosage units each containing as the sole contraceptively effective ingredient of a progestogen, or as effective ingredient for HRT a progestogen with or without an estrogen or an estrogen only, and further two or more dosage units comprising an anti-progestogen. One of the anti-progestogen is administered at the beginning and the others regularly divided throughout the cycle, preferably one only in the middle of the cycle.
Patent NZ-504422-A (NZ)
Title: Patient worn apparatus for portable ultrasonic treatment of carpal tunnel syndrome
Inventor: RYABY JACK P
IPC: A61N7/00
Filed: 1998-10-09
Abstract: An apparatus for therapeutically treating carpal tunnel or hand/wrist injuries using ultrasound.  The apparatus (10) includes at least one ergonomically constructed ultrasonic transducer configured to cooperate with a placement module or strip for placement in proximity to the carpal tunnel or hand/wrist injury. The apparatus (10) also utilizes a portable, ergonomically constructed main operating unit (12) constructed to fit within a pouch (18) worn by the patient. In operation, at least one ultrasonic transducer positioned adjacent the carpal tunnel or hand/wrist injury is excited for a predetermined period of time. To ensure that at least one ultrasonic transducer is properly positioned, and to insure compliance with a treatment protocol, a safety interlock (70) is provided to prevent inadvertent excitation.
Patent NZ-504735-A (NZ)
Title: Alpha-interferon polymer conjugates, preparation and use
Inventor: GILBERT CARL W
IPC: A61K47/48
Filed: 1998-12-16
Abstract: Described is a pharmaceutical composition comprising a mixture of alpha interferon polymer conjugate positional isomers, wherein one of the positional isomers comprises an alpha interferon covalently conjugated to a substantially non-antigenic polymer at a histidine residue on the alpha interferon.
Patent NZ-510446-A (NZ)
Title: Gastrointestinal delivery of LH-RH peptide analogues
Inventor: DELANSORNE REMI
IPC: A61K38/04
Filed: 1999-09-23
Abstract: The use of alpha -cyclodextrin for the preparation of pharmaceutical compositions for the oral administration of luteinizing hormone-releasing hormone (LH-RH) peptide analogues is described.  Oral pharmaceutical compositions containing LH-RH peptide analogues in combination with alpha -cyclodextrin are also described.
Patent NZ-513999-A (NZ)
Title: Coloured noodles
Inventor: TOH TIAN-SENG
IPC: A23L7/109
Filed: 2001-09-05
Abstract: A coloured precooked pasta product in which at least one colour-precursor compound such as tocopherols, carotenoids, flavonoids or polyphenols of the pasta dough has been reacted under high temperature with alkaline compound to develop the colour of the pasta.  Method for colouring pasta dough by contacting, at least of one pregeletinized pasta dough surface with an alkaline compound capable to react with at least one colour-precursor compound present in the dough, at a temperature and during a time sufficient for developing the colour.
Patent NZ-516913-A (NZ)
Title: Novel vitamin D analogues
Inventor: BRETTING CLAUS AAGE SVENSGAARD
IPC: A61P17/02
Filed: 2000-07-11
Abstract: Compounds of formula (I), methods of their production, and the use thereof to treat conditions characterized by abnormal cell differentiation and/or cell proliferation.
Patent NZ-520301-A (NZ)
Title: Pesticidal compositions comprising a synergistic combination of a carbamic acid derivative and a 4-(haloalkyl)phenoxyphenylurea derivative and their use as protecting agents
Inventor: VERBRUGGEN LUC ROSALIA MICHAEL
IPC: A01N25/12
Filed: 2001-02-27
Abstract: A composition comprising: i) One or more carbamic acid derivatives of the formula (I), where R1 is hydrogen, fluorine, chlorine, C1-6alkyl, trifluoromethyl, hydroxy or methoxy; X is oxygen, carbonyl, methylene, sulfur or sulfonyl; Z is oxygen, methylene or sulfur; Y is oxygen or sulfur and R2 is C1-6alkyl. ii) One or more 4-(haloalkyl)phenoxyphenylurea derivatives of formula (II), where: A, B, X, and Z are independently fluorine or chlorine; n is 0, 1, 2 or 3; p is 0 or 1; Y is a C1-6haloalkyl group; R1 is hydrogen or ûSNR2R3 where R2 is C1-6alkyl and R3 is C1-6alkyl or ûCOR4 or ûCOOR4 where R4 is C1-6alkyl, or R2 and R3 together represent an alkylene group having 4 or 5 carbon atoms and optionally substituted by an alkoxycarbonyl group of up to 6 carbon atoms in the alkyl moiety, The carbamic acid derivative and the 4-(haloalkyl)phenoxyphenylurea derivative are present in the composition in respective proportions such as to provide a synergistic effect against insects and/or acari. Also described is an agronomic or therapeutic composition comprising the composition described above and at least one agronomically or therapeutically acceptable carrier. Also described is a protective composition comprising the composition described above and at least one additive suitable for the formulation of paints, coatings or varnishes. Also described is the use of the composition for the control of insects and/or acari.
Patent NZ-521691-A (NZ)
Title: Method for automatically collecting consumer product interest data for deliver specifically targeted advertising
Inventor: HOGAN THOMAS
IPC: G06Q30/00
Filed: 2001-04-04
Abstract: Automatic collection of consumer product interest data utilizes a consumer assist device, CAD (25), to allow the consumer to make and record a "first selection" of a product. The consumer assist device then provides the consumer with at least one option relating to the product. Each time the consumer makes a selection to view one of the options available (a "second selection"), the second selection is recorded, and the record contains the same type of information contained in records relating to the first selection of the product. A comparison is performed between the products selected and products purchased. If product selected was purchased, correlation is recorded. Collected data are provided to users (70) according to authorization levels.
Patent NZ-524603-A (NZ)
Title: New retinoids for the treatment of emphysema
Inventor: LAPIERRE JEAN-MARC
IPC: C07D295/14
Filed: 2001-09-24
Abstract: Disclosed herein are retinoid compounds and methods for their synthesis, the use of such compounds for the preparation of medicaments for treating or preventing emphysema, cancer and dermatological disorders and pharmaceutical compositions suitable for the treatment or prevention of emphysema, cancer and dermatological disorders.
Patent NZ-527513-A (NZ)
Title: A gaming machine with bonus feature
Inventor: ROUKIS GEORGE
IPC: A63F13/06
Filed: 2003-08-11
Abstract: A gaming machine has a display means and a game control means arranged to control images on the display means. The game control means is arranged to play a game wherein one or more random events are caused to be displayed on the display means and, if a predefined winning event results, the machine awards a prize to a player, wherein the game includes a bonus feature. The bonus feature when triggered results in the display of a plurality of devices, each of which animates to reveal a number, a prize awarded being a product of the numbers displayed by the devices.
Patent NZ-529033-A (NZ)
Title: Carboxylic acid substituted oxazole derivatives for use as PPAR-alpha and -gamma activators in the treatment of diabetes
Inventor: BINGGELI ALFRED
IPC: A61P3/00
Filed: 2002-05-06
Abstract: Carboxylic acid substituted oxazole derivative compounds of formula (I) and their pharmaceutically acceptable salts and esters that may be useful as PPAR-a and PPAR-g activators in the treatment of diabetes are disclosed, wherein R1 to R7 and n are as defined in the specification.
Patent NZ-530976-A (NZ)
Title: Adenosine A3 receptor agonists
Inventor: ELZEIN ELFATIH
IPC: A61P15/08
Filed: 2002-08-06
Abstract: Disclosed are compounds of the formula (I) that are A3 adenosine receptor agonists, useful for treating various disease states, including cancer, cardiac ischemia, leukopenia, and neutropennia, wherein: R1 is optionally substituted lower alkyl, optionally substituted cycloalkyl, optionally substituted aryl, or optionally substituted heteroaryl; X is a covalent bond or optionally substituted alkylene; R1 is R4-Z-Y-CºC- or optionally substituted pyrazolyl, in which Y is optionally substituted alkylene, Z is oxygen, sulfur or NH-, and R4 is optionally substituted aryl or optionally substituted heteroaryl; and R3 is hydroxymethyl or C(O)-NR5R6, in which R5 and R6 are independently hydrogen or lower alkyl.
Patent NZ-534014-A (NZ)
Title: A photographic display device which highlights or allows a selected subject to be emphasised to a viewer
Inventor: FRAMPTON SEAN
IPC: G09F1/12
Filed: 2004-07-09
Abstract: A photographic display device (1) comprises: (a) an elongated rail ; (b) a channel (2) in the rail, (c) a board (3) extending from the base rail, the board (3) having a lower edge (4) which is complementary to and inserted into the channel (2) of the rail, and (d) a photographic image (5) mounted on one major surface of the board, the photographic image being of an object or person(s) and the image and the board being contoured to highlight the outline of the object or person(s) rather than the background of the image.
Patent NZ-534292-A (NZ)
Title: Anti-viral compounds to ameliorate effects of picornaviridae infection
Inventor: ANDERSON DAVID ANDREW
IPC: A61P31/12
Filed: 2003-01-30
Abstract: Disclosed is the use of a compound in the manufacture of a medicament to control spread of Picornaviridae infection in a human, said compound selected from the compounds of Formulae I-IV. Also disclosed is a method of ameliorating the effects of Picornaviridae infection in a non-human vertebrate animal said method comprising administering to said animal a compound selected from the compounds of Formulae I-IV.
Patent NZ-537470-A (NZ)
Title: 1-phenylalkyl-piperazines having affinity for serotoninergic receptors, pharmaceutical compositions containing them and uses thereof for reducing the frequency of bladder contractions
Inventor: LEONARDI AMEDEO
IPC: C07D295/155
Filed: 2003-06-16
Abstract: Compounds of formula (I) are described (R and R1 are a wide range of substituents, Q is CO, CHOH or CHOR2, R2 is alkyl, alkenyl, alkynyl or cycloalkyl group, each of which is optionally substituted, or is alkanoyl, alkanoyoxy, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, aminothiocarbonyl, alkylaminothiocarbonyl or dialkylaminothiocarbonyl, R3 is H, alkyl, -alkenyl, alkynyl, cycloalkyl, aryl or heterocyclic group, each of which is optionally substituted, n is 1 or 2, A is a bond or a methylene or ethylene group and R4 is an aryl or heteroaryl group, either of which is optionally substituted) have affinity for serotoninergic receptors. These compounds and their enantiomers, diastereoisomers, N-piperazine oxides, polymorphs, solvates and pharmaceutically acceptable salts are useful in the treatment of patients with neuromuscular dysfunction of the lower urinary tract and diseases related to 5-HT1A receptor activity.
Patent NZ-539872-A (NZ)
Title: Formulations containing melatonin, ginkgo biloba, and biotin
Inventor: SCHMID HANS W
IPC: A61J1/06
Filed: 2003-10-30
Abstract: Disclosed is a composition comprising, as active ingredients: melatonin or a derivative thereof, ginkgo biloba and biotin as a topical formulation. Compositions of the type claimed are useful for promoting hair growth and the treatment of alopecia.
Patent NZ-541089-A (NZ)
Title: Method for preparing methyl 2-diphenylmethylsulfinylacetate
Inventor: ROSE SEBASTIEN
IPC: C07C317/44
Filed: 2004-01-08
Abstract: Disclosed is a method for preparing methyl 2-diphenylmethylsulfinylacetate (MDMSA) comprising the steps of: (i) conversion of benzhydrol into methyldiphenylmethylthio-acetate; and (ii) conversion of methyldiphenylmethylthioacetate into methyl-2-diphenylmethylsulfinylacetate. Also disclosed is the use of the above process in the manufacture of modafinil.
Patent NZ-544381-A (NZ)
Title: System and method for modelling a flight and invoicing the flight providers for services used
Inventor: GRIFFIN MARK RAYMOND
Filed: 2006-03-02
Abstract: A system for modelling a flight of an aircraft is disclosed. The system includes at least one data acquisition system for sourcing flight details from at least one data source and a processing system for compiling a flight model from the flight details. The flight details represent the activity of the aircraft within a single flight information region (hereinafter FIR). The flight model indicates the activity of the aircraft over the duration of the flight in two or more FIRs or for an entire flight undertaken in a single FIR. By using the flight details, the processing system is capable of determining utilised services from available services, within a the FIR, to the flight.
Patent NZ-545775-A (NZ)
Title: Proteasome inhibitors and method of using the same
Inventor: MENTA ERNESTO
IPC: C07F5/04
Filed: 2004-08-13
Abstract: Disclosed are compounds of formula (I), wherein Q is -B(OH)2, -B(OR14)2 or a cyclonic boronic ester, R1 is alkyl, alkenyl, alkynyl or cycloalkyl, and the remaining substituents are as defined in the specification. Also disclosed are intermediates of formula (II) and processes for their preparation. The compounds can modulate apoptosis such as by inhibition of proteasome activity, and can be used in treating diseases such as cancer, human immunodeficiency virus (HIV) infection or inflammatory disorders resulting from transplantation rejection, arthritis, infection, inflammatory bowel disease, asthma, osteoporosis, osteoarthritis, psoriasis, restenosis, and autoimmune diseases.
Patent NZ-547339-A (NZ)
Title: Gradient induction heating of a workpiece using multiple coils and variable frequency power supplies
Inventor: FISHMAN OLEG S
IPC: H02M7/48
Filed: 2006-05-19
Abstract: An apparatus and process for gradient induction heating or melting of a workpiece with a plurality of induction coils, each induction coil being connected to a power supply that may have a tuning capacitor connected across the input of an inverter. The coils are sequentially disposed around the workpiece. The inverter has a pulse width modulated AC power output that may be in synchronous control with the pulse width modulated AC power outputs of the other power supplies via a control line between the controllers of all power supplies.
Patent NZ-554686-A (NZ)
Title: Cai-based systems and methods for the localized treatment of ocular and other diseases
Inventor: ROBINSON GARY
IPC: A61K31/4192
Filed: 2005-09-26
Abstract: The disclosure relates to CAI (carboxy-amido-triazole) compounds and formulations thereof, that are suitable for use in the localized treatment of non-life threatening diseases. Method of preparing a sterile, aqueous formulation comprising a CAI compounds of the CAI free base and CAI prodrug microcrystallines, microparticles, emulsions, is also disclosed. The disclosure further provides methods for treating non-life threatening ocular disease using a medicament comprising CAI compounds (wherein the medicament is formulated for local ocular administration), wherein the medicament is effective and has little or no adverse side effects.
Patent NZ-556333-A (NZ)
Title: Controlled defrosting and proving of frozen dough pieces
Inventor: WILLETT PAUL EATON
Filed: 2007-07-05
Abstract: A dough conditioning apparatus for frozen dough includes an enclosure, at least one tray or conveyance for supporting at least one frozen dough piece within the enclosure, a gas director to direct a conditioning gas directly onto frozen dough within the enclosure, humidity and temperature sensors for respectively measuring the humidity and temperature of the conditioning gas, and a gas controller which controls the duration of the conditioning gas onto the frozen dough according to the output of the humidity and temperature sensor. The dough may be kept frozen within the conditioner for a period of time before the thawing conditioning commences.
Patent NZ-563604-A (NZ)
Title: Compounds for treatment of inflammation, diabetes and related disorders
Inventor: NEOGI PARTHA
IPC: C07D213/64
Filed: 2002-11-27
Abstract: Disclosed are compounds of formulae (XI), wherein the substituents are as defined in the specification. Particularly disclosed compound of formula (XI) is: 3-(3,5-Dimethoxyphenyl)-2-(4-hydroxyphenyl)-N,N-dimethylacrylamide. The compounds are useful in the treatment of diabetes, inflammatory and immunological disease, hyperlipidemia and coronary heart disease.
Patent NZ-567089-A (NZ)
Title: Humeral component of a shoulder joint prosthesis with stem axis offset from epiphyseal axis
Inventor: PONCET DIDIER
IPC: A61F2/00
Filed: 2006-10-02
Abstract: Disclosed is a humeral component (2) of a reverse shoulder prosthesis. The component includes: an elongate stem part (4) for location within the intramedullary cavity of the humerus, the stem part having a planar proximal face; and an epiphyseal part (8) having a concave bearing surface (12) for articulation with the convex bearing surface of a glenoid component. The epiphyseal part has: a planar distal face which abuts the proximal face of the stem part when the stem and epiphyseal parts are assembled; and a bone facing surface extending between the planar distal face and the concave bearing surface, which is adapted for contact with bone tissue. The elongate stem part defines a stem axis, with the proximal face being perpendicular to the stem axis. The concave bearing surface of the epiphyseal part defines an epiphyseal axis, the epiphyseal axis being offset posteriorly relative to the stem axis.
Patent NZ-568838-A (NZ)
Title: Method of decreasing the rate of photoyellowing in paper by the application of aqueous thiocyanate salts
Inventor: SHEVCHENKO SERGEY M
IPC: C01C3/20
Filed: 2006-12-14
Abstract: Disclosed is a method of decreasing the rate of photoyellowing in paper containing mechanical pulp comprising: applying an aqueous solution containing an effective amount of one or more salts of thiocyanic acid (such as sodium thiocyanate, potassium thiocyanate, ammonium thiocyanate or calcium thiocyanate) on the surface of a paper sheet in a papermaking process.